← Evidence map

ReviewMolecular and cellular endocrinology2022

Irisin reduces inflammatory signaling pathways in inflammation-mediated metabolic syndrome.

John J Slate-Romano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

55 papers cite it

2022
2023
2024
2025
2026
2027
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35569582